2004年至2014年美国子宫切除术后阿片类药物处方获取趋势及手术路径变化
基于Truven Health Analytics MarketScan数据库,2004至2014年共识别793,016例子宫全切术,其中96%来自商业索赔数据库。研究期间腹腔镜子宫全切占比从17.0%升至61.9%,腹式从60.2%降至25.6%,阴式从22.8%降至12.6%;出院时开具并获取阿片类药物的患者比例从25.6%升至82.1%(P<.001),处方量亦增加。
要点
- 2004至2014年子宫全切路径向微创转变,腹腔镜占比从17.0%升至61.9%。
- 出院时获取阿片类处方比例从25.6%升至82.1%(P<.001),处方量亦增加。
- 微创路径增加的同时阿片类药物获取量仍上升,提示处方行为可能 contribute 于慢性阿片依赖。
核心结论
- 2004至2014年子宫全切术后为疼痛开具并获取的阿片类药物大幅增加,尽管微创子宫全切路径同期增加,阿片类处方获取仍上升。
- 作者指出,鉴于当前阿片类 epidemic,医生必须认识到术后处方行为可能 contribute 于慢性阿片类使用,提高对术后阿片类处方行为的警觉对降低慢性阿片依赖风险至关重要。
研究设计与样本
- 利用Truven Health Analytics MarketScan研究数据库(含商业索赔与 encounter 数据库及 Medicare 补充与协调福利数据库),通过 CPT-4 和 ICD-9 编码识别2004至2014年因良性指征行子宫全切的所有患者。
- 子宫全切路径分为腹式、腹腔镜和阴式;MarketScan数据库仅捕获零售或邮购药房配药,不捕获住院院内药房配药;识别每次就诊出院时患者获取的阿片类药物天数。
- 采用描述性统计总结整个研究期间数据;虽为纯描述性文章,进一步分析仅用于探索目的,连续变量和分类变量分别采用方差分析和 χ2 检验,多元线性回归模型描述变量与术后阿片类处方之间的关联。
主要发现
- 共识别793,016例因良性指征行子宫全切的患者,其中96%来自商业索赔与 encounter 数据库。
- 研究期间总体子宫全切路径为腹式40.5%、腹腔镜42.0%、阴式17.5%;腹式从60.2%降至25.6%(Δ=34.58,95%CI 33.96-35.20),腹腔镜从17.0%升至61.9%(Δ=44.83,95%CI 44.21-45.44),阴式从22.8%降至12.6%(Δ=10.25,95%CI 9.77-10.73)。
- 出院时开具并获取阿片类药物的患者比例从2004年的25.6%升至2014年的82.1%(Δ=56.50,95%CI 55.88-57.13,P<.001),适用于所有子宫全切路径;阿片类药物处方量亦增加。
临床怎么用
- 作者认为,医生必须认识到术后处方行为可能 contribute 于慢性阿片类使用。
- 作者指出,提高对术后阿片类处方行为的警觉对降低慢性阿片依赖风险至关重要。
局限性
- MarketScan数据库仅捕获零售或邮购药房配药,不捕获住院院内药房配药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The opioid epidemic in the United States is a public health emergency. Minimally invasive surgical technology has decreased length of hospital stay, improved postoperative recovery, and decreased postoperative pain. Hysterectomy is one of the most commonly performed surgeries in the United States. Increasing trends in minimally invasive gynecologic surgery are expected to reduce patients' postoperative pain. It is unclear whether this assumption has resulted in decreasing postoperative opioid prescriptions or patient need for these prescriptions, as prescribing patterns may be contributing to the current opioid public health emergency. OBJECTIVE: We sought to describe opioid prescribing and patient procurement practices for postoperative pain at time of discharge for benign hysterectomy from 2004 through 2014 using the Truven Health Analytics MarketScan Research Database. The trends of the route of hysterectomy over this time period were concomitantly described to reflect the movement toward more minimally invasive approaches. STUDY DESIGN: The Truven Health Analytics MarketScan Research Database including the Commercial Claims and Encounters Database, and the Medicare Supplemental and Coordination of Benefits Database were utilized. Current Procedural Terminology, 4th Edition, and International Classification of Diseases, Ninth Revision, codes identified all patients who underwent a hysterectomy for benign indications from 2004 through 2014. Hysterectomy routes were categorized into abdominal, laparoscopic, and vaginal. The MarketScan database captures prescriptions filled at a retail or mail-order pharmacy and does not capture prescriptions filled within the inpatient, hospital facility. The days of opioids procured by patients at the time of discharge were identified for each encounter. Descriptive statistics were used to summarize data within the entire study period. Although this article is purely descriptive, further analyses were conducted for exploratory purposes only. analysis of variance and χ2 analyses were used for continuous and categorical variables, respectively. Multiple linear regression models were used to describe associations between variables of interest and postoperative opioid prescriptions. RESULTS: We identified 793,016 patients who underwent a hysterectomy for benign indications from 2004 through 2014. Of these, 96% were identified from the Commercial Claims and Encounters Database. During the study period, the overall route of hysterectomy was categorized into 40.5% abdominal, 42.0% laparoscopic, and 17.5% vaginal hysterectomy. The route of hysterectomy changed from 60.2-25.6% (a decrease of Δ = 34.58; 95% confidence interval, 33.96-35.20) for abdominal, 17.0-61.9% (an increase of Δ = 44.83; 95% confidence interval, 44.21-45.44) for laparoscopic, and 22.8-12.6% (a decrease of Δ = 10.25; 95% confidence interval, 9.77-10.73) for vaginal. At discharge, the percentage of patients who were prescribed opioids and filled them increased from 25.6-82.1% (an increase of Δ = 56.50; 95% confidence interval, 55.88-57.13 with P < .001) from 2004 through 2014 for all hysterectomy routes. Additionally, the quantity of opioids prescribed also increased. CONCLUSION: Opioid prescriptions filled for postoperative pain after hysterectomy substantially increased from 2004 through 2014. Opioid prescription procurement has increased despite a concomitant increase in minimally invasive hysterectomy routes. In light of the current opioid epidemic, physicians must recognize that postoperative prescribing practices may contribute to chronic opioid use. Heightened awareness of opioid prescribing practices following surgery is critically important to decrease risk of development of chronic opioid dependence.
引用
- Thompson JC, Komesu YM, Qeadan F, et al. Trends in patient procurement of postoperative opioids and route of hysterectomy in the United States from 2004 through 2014. Am J Obstet Gynecol. 2018. PMID: 30017674. doi:10.1016/j.ajog.2018.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。